US FDA grants fast track status for Oncolytics’ Reolysin to treat metastatic breast cancer

Oncolytics Biotech, a biotechnology company, announced that the United States Food and Drug Administration (FDA) has granted Fast Track designation for Reolysin, the company's proprietary immuno-oncology viral agent, for the…

Continue ReadingUS FDA grants fast track status for Oncolytics’ Reolysin to treat metastatic breast cancer

Natco Pharma launches generic blood cancer drug Pomalidomide in India

NEW DELHI: Natco Pharma today said it has launched a generic version of pomalidomide capsules, used in treatment of a type of blood cancer, in India."Pomalidomide is a thalidomide analogue indicated, in combination with dexamethasone,…

Continue ReadingNatco Pharma launches generic blood cancer drug Pomalidomide in India